Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228046 · ClinicalTrials.gov registry record · Phase 4
Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
A Phase 4 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00228046 is a Phase 4 study that has completed, run by Stony Brook University. The registered enrollment target is 40 participants.
The verdict
NCT00228046, a Phase 4 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will assess whether adding a mood stabilizer, divalproex sodium, to stimulant treatment is more effective than stimulant treatment alone in reducing aggressive behavior among children with attention deficit hyperactivity disorder (ADHD).
Interventions
- DRUG Methylphenidate
- DRUG Divalproex Sodium
- DRUG Dextroamphetamine
- BEHAVIORAL Family Counseling
- DRUG Mixed Amphetamine Salts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00228046
The ClinicalTrials.gov registry entry for NCT00228046 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Methylphenidate is the first listed.
NCT00228046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00228046 about?
NCT00228046 is a clinical study titled "Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder". This study will assess whether adding a mood stabilizer, divalproex sodium, to stimulant treatment is more effective than stimulant treatment alone in reducing aggressive behavior among children with attention deficit hyperactivity disorder (ADHD).
What is the current status of trial NCT00228046?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2004-01. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00228046?
The interventions under investigation include: Methylphenidate (DRUG), Divalproex Sodium (DRUG), Dextroamphetamine (DRUG), Family Counseling (BEHAVIORAL), Mixed Amphetamine Salts (DRUG).
Who is sponsoring clinical trial NCT00228046?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.